Hydrocortisone
Hydrocortisone 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Metastatic Castration-resistant Prostate Cancer (mCRPC)、Prostatic Neoplasms。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
3 项
已进入 III/IV 期
22 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Merck Sharp & Dohme LLC
- University of Baghdad
- University of Thessaly
- University of Zurich
- Institut National de la Santé Et de la Recherche Médicale, France
- Children's Oncology Group
- Assistance Publique - Hôpitaux de Paris
- Tzu Chi University
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
Iraq、Greece、瑞士、法国、美国、澳大利亚、加拿大、新西兰、Puerto Rico、中国台湾、Brazil、Chile
正在招募患者的 Hydrocortisone 研究
Hard Tissue Augmentation With or Without Connective Tissue Graft in Immediate Esthetic Implants
不适用招募中IraqNCT07333534Stress and Musculoskeletal Health in Employees
不适用招募中GreeceNCT06488547Cerebrovascular Disease: Quality of Life (CODE: QoL)
不适用招募中瑞士NCT06443268Child Cognitive-Affective Resilience Following 13-11 Event : A Pluridisciplinary Study of Intergenerational Transmission of a Traumatic Event
不适用招募中法国NCT07203443Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
III 期招募中美国澳大利亚加拿大新西兰NCT03959085Adaptive Platform Trial for Personnalisation of Sepsis Treatment in Children and Adults: a Multi-national, Treatable Traits-guided, Adaptive, Exploratory, Bayesian Basket Trial
II 期招募中法国NCT06381661FR-taVNS Tinnitus Tria
不适用招募中中国台湾NCT07711639A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
III 期招募中美国澳大利亚Brazil加拿大NCT06136650O2 Consumption And CO2 Production After Hemodynamic Optimization In Shock
不适用招募中意大利NCT07107724Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
II 期招募中OmanNCT07112456Hair Cortisol as Marker of Chronic Stress in Preterm and Term Fathers - Fathair-study
不适用招募中德国NCT05969431IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion
不适用招募中美国NCT07361874Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study
不适用招募中ThailandNCT06937918Effect of Intranasal Oxytocin on Emotion Recognition and Acute Psycho-Social Stress-induced Cortisol Increase in Patients With Central Diabetes Insipidus and Healthy Controls
II 期招募中瑞士NCT06676774Venetoclax Basket Trial for High Risk Hematologic Malignancies
I 期招募中美国NCT05292664Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
不适用招募中法国NCT06842316Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma
不适用招募中美国NCT06344143Evaluation of Emotion-related Salivary Molecular Biomarkers
不适用招募中法国NCT07320040Clinical Study on Circadian Genes Dysregulation in Patients With Glucocorticoid Disorders
不适用招募中意大利NCT04374721Venous Congestion And Delirium After Cardiac Surgery
不适用招募中中国NCT07285187FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
II 期招募中澳大利亚新西兰NCT06409364Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
IV 期招募中中国NCT07383103Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?
不适用招募中丹麦NCT06896682Imaging CRF X NOP Interactions in Alcohol Use Disorder
早期 I 期招募中美国NCT07612631
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。